Accolade, Inc. (ACCD)
NASDAQ: ACCD · IEX Real-Time Price · USD
8.34
-0.85 (-9.30%)
Apr 26, 2024, 11:29 AM EDT - Market open

Company Description

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.

It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services.

The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs.

Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Accolade, Inc.
Accolade logo
Country United States
Founded 2007
IPO Date Jul 2, 2020
Industry Health Information Services
Sector Healthcare
Employees 2,370
CEO Rajeev Singh

Contact Details

Address:
660 W. Germantown Pike Suite 500
Plymouth Meeting, Pennsylvania 19462
United States
Phone 610-834-2989
Website accolade.com

Stock Details

Ticker Symbol ACCD
Exchange NASDAQ
Fiscal Year March - February
Reporting Currency USD
IPO Price $22.00
CIK Code 0001481646
CUSIP Number 00437E102
ISIN Number US00437E1029
Employer ID 43-2117836
SIC Code 7389

Key Executives

Name Position
Rajeev Singh Chairman of the Board and Chief Executive Officer
Robert Cavanaugh President
Stephen H. Barnes CPA Chief Financial Officer and Treasurer
Kristen Bruzek Senior Vice President of Operations
Colin McHugh Chief Accounting Officer
Todd Friedman Senior Vice President of Investor Relations
Richard Eskew Executive Vice President, General Counsel, CCO and Secretary
Kelsi McDonald Harris Chief People Officer and Senior Vice President
Drew Garner Executive Vice President of Engineering
Dr. Shantanu Nundy M.B.A., M.D. Executive Vice President, Chief Health Officer and Member of the Medical Advisory Board

Latest SEC Filings

Date Type Title
Apr 26, 2024 S-8 Securities to be offered to employees in employee benefit plans
Apr 26, 2024 10-K Annual Report
Apr 25, 2024 8-K Current Report
Apr 18, 2024 144 Filing
Apr 18, 2024 144 Filing
Apr 18, 2024 144 Filing
Apr 11, 2024 144 Filing
Apr 11, 2024 144 Filing
Apr 11, 2024 144 Filing
Apr 2, 2024 144 Filing